Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Palatin Technologies (NY: PTN )

1.090 -0.080 (-6.84%)
Official Closing Price Updated: 8:00 PM EST, Nov 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Palatin Technologies

< Previous 1 2 3 4 Next >
Earnings Scheduled For September 29, 2021
Companies Reporting Before The Bell • AGM Gr Hldgs (NASDAQ:AGMH) is estimated to report earnings for its first quarter. • Palatin Technologies (AMEX:PTN) is... 
Via Benzinga
Palatin Technologies Stock Moves Higher After Outlining Plans For Dry Eye Disease Treatment
Palatin Technologies Inc (NYSE: PTN) has completed an End-of-Phase 2 (EOP2) meeting with the FDA for PL9643 for the treatment of dry eye disease (DED). Palatin... 
Via Benzinga
Exposures Product Safety
Return On Capital Employed Overview: Palatin Technologies
During Q3, Palatin Technologies (AMEX:PTN) brought in sales totaling $88.74 thousand. However, earnings decreased 29.88%, resulting in a loss of $6.49 million. In Q2, Palatin... 
Via Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
Earnings Scheduled For May 17, 2021
Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) rose 108.2% to $9.16 in pre-market trading after dropping more than 10% on Monday. Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.